- Home
- FITBO vs MRK Comparison
FITBO vs MRK Comparison
Compare FITBO & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FITBO
- MRK
- Stock Information
- Founded
- FITBO N/A
- MRK 2000
- Country
- FITBO United States
- MRK United States
- Employees
- FITBO 18616
- MRK N/A
- Industry
- FITBO Major Banks
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- FITBO Finance
- MRK Health Care
- Exchange
- FITBO Nasdaq
- MRK Nasdaq
- Market Cap
- FITBO N/A
- MRK 218.8B
- IPO Year
- FITBO N/A
- MRK N/A
- Fundamental
- Price
- FITBO $20.53
- MRK $86.77
- Analyst Decision
- FITBO
- MRK Buy
- Analyst Count
- FITBO 0
- MRK 15
- Target Price
- FITBO N/A
- MRK $105.14
- AVG Volume (30 Days)
- FITBO N/A
- MRK 13.0M
- Earning Date
- FITBO N/A
- MRK 10-30-2025
- Dividend Yield
- FITBO N/A
- MRK 3.82%
- EPS Growth
- FITBO N/A
- MRK 20.41
- EPS
- FITBO N/A
- MRK 6.49
- Revenue
- FITBO N/A
- MRK $63,616,000,000.00
- Revenue This Year
- FITBO N/A
- MRK $1.84
- Revenue Next Year
- FITBO N/A
- MRK $5.24
- P/E Ratio
- FITBO N/A
- MRK $13.07
- Revenue Growth
- FITBO N/A
- MRK 1.82
- 52 Week Low
- FITBO N/A
- MRK $73.31
- 52 Week High
- FITBO N/A
- MRK $110.19
- Technical
- Relative Strength Index (RSI)
- FITBO 43.45
- MRK 56.99
- Support Level
- FITBO $20.31
- MRK $83.16
- Resistance Level
- FITBO $20.91
- MRK $85.50
- Average True Range (ATR)
- FITBO 0.25
- MRK 2.08
- MACD
- FITBO -0.06
- MRK -0.13
- Stochastic Oscillator
- FITBO 26.51
- MRK 45.13
About FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).